NS Pharma, Inc.
Donald Foy has an extensive background in sales and leadership roles within the pharmaceutical industry. Donald has held positions such as Head of Sales at NS Pharma, Inc., Senior Area Sales Director at Idorsia Pharmaceuticals US Inc., Senior Zone Director at Takeda, and various sales management roles at Eli Lilly and Company. Donald also has experience in patient advocacy and state government affairs, as well as membership sales and marketing at the American Medical Association. Donald holds a Bachelor's Degree in Economics from Indiana University Bloomington.
This person is not in the org chart
This person is not in any offices
NS Pharma, Inc.
2 followers
NS Pharma, Inc. (NSP) located in Paramus New Jersey is a subsidiary of Nippon Shinyaku Co., Ltd. Founded in 1999 in the United States, NSP is engaged in clinical studies and partnering with global pharmaceutical companies, venture companies and research institutes. NSP serves as a contact point for connecting Japan/Asia and the world, developing drug candidates invented in Japan and out-license them to the world. From the world to Japan/Asia, NSP in-license promising drug candidates to the Japanese/Asian Markets. In coordination with parent company, Nippon Shinyaku, Co., Ltd., NSP will first and foremost develop and supply safe and highly effective pharmaceuticals through clinical studies. NSP aims to be an indispensable entity in the healthcare industry in line with the guidelines for action “Challenge”, “Speed”, and “Investigation”.